National Institutes of Health (NIH) review of evidence in phenylalanine hydroxylase deficiency (phenylketonuria) and recommendations/guidelines for therapy from the American College of Medical Genetics (ACMG) and Genetics Metabolic Dietitians International (GMDI)

Molecular Genetics and Metabolism

Volumn 112, Issue 2, 2014, Pages 85-86

  Greene, Carol L ^a   Longo, Nicola ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; SAPROPTERIN; BIOPTERIN;

ADJUVANT THERAPY; CAREGIVER; DIET RESTRICTION; ENVIRONMENTAL FACTOR; EXECUTIVE FUNCTION; GENOTYPE; HETEROZYGOTE; HUMAN; MEDICAL SOCIETY; METABOLIC DISORDER; NATIONAL HEALTH ORGANIZATION; NOTE; PHENYLKETONURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BLOOD; DIET THERAPY; FEMALE; PHENYLKETONURIAS; PREGNANCY;

BIOPTERIN; DIET THERAPY; FEMALE; HUMANS; PHENYLKETONURIAS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY;

EID: 84901600919     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2014.03.005     Document Type: Note

References (7)

1. Camp K.M., Parisi M.A. Phenylketonuria scientific review conference: state of the science and future research needs. Mol. Genet. Metab. 2014, 112:87-122. (this issue).
2. Vockley J., Andersson H.C., Antshel K.M., Braverman N.E., Burton B.K., Frazier D.M., Mitchell J., Smith W.E., Thompson B.H., Berry S.A. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet. Med. 2014, 16:188-200.
3. Singh R.H., Rohr F., Frazier D., Cunningham A., Mofidi S., Ogata B., Splett P.L., Moseley K., Huntington K., Acosta P.B., Vockley J., Van Calcar S.C. Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet. Med. 2014, 16:121-131.
4. Ris M.D., Williams S.E., Hunt M.M., Berry H.K., Leslie N. Early-treated phenylketonuria: adult neuropsychologic outcome. J. Pediatr. 1994, 124:388-392.
5. Christ S.E., Huijbregts S.C., de Sonneville L.M., White D.A. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol. Genet. Metab. 2010, 99(Suppl. 1):S22-S32.
6. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics 2001, 108:972-982.
7. Lindegren M.L., Krishnaswami S., Fonnesbeck C., Reimschisel T., Fisher J., Jackson K., Shields T., Sathe N.A., McPheeters M.L. Adjuvant Treatment for Phenylketonuria (PKU) 2012, Agency for Healthcare Research and Quality (US), Rockville (MD), (Report No.: 12-EHC035-EF).